[HTML][HTML] NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential

K Li, T Yao, Y Zhang, W Li, Z Wang - International journal of …, 2021 - ncbi.nlm.nih.gov
The nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA (lncRNA)
that is upregulated in a variety of human cancer types. Increasing evidence has shown that …

[HTML][HTML] Research progress on the interaction between oxidative stress and platelets: another avenue for cancer?

X Zhang, S Yu, X Li, X Wen, S Liu, R Zu, H Ren… - Pharmacological …, 2023 - Elsevier
Oxidative stress (OS) is a chemical imbalance between an oxidant and an antioxidant,
causing damage to redox signaling and control or causing molecular damage. Unbalanced …

Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post‐Photothermal Therapy

Y Li, K Zhang, Y Wu, Y Yue, K Cheng, Q Feng, X Ma… - Small, 2022 - Wiley Online Library
Tumor antigens released from tumor cells after local photothermal therapy (PTT) can
activate the tumor‐specific immune responses, which are critical for eliminating the residual …

The redox protein high-mobility group box 1 in cell death and cancer

R Chen, J Zou, R Kang, D Tang - Antioxidants & redox signaling, 2023 - liebertpub.com
Significance: As a redox-sensitive protein, high-mobility group box 1 (HMGB1) is implicated
in regulating stress responses to oxidative damage and cell death, which are closely related …

Parkin activates innate immunity and promotes antitumor immune responses

M Perego, M Yeon, E Agarwal, AT Milcarek… - The Journal of Clinical …, 2024 - jci.org
The activation of innate immunity and associated interferon (IFN) signaling have been
implicated in cancer, but the regulators are elusive and links to tumor suppression remain …

Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of noncanonical functions of C1s

MV Daugan, M Revel, J Russick… - Cancer Immunology …, 2021 - AACR
The complement system plays a complex role in cancer. In clear cell renal cell carcinoma
(ccRCC), local production of complement proteins drives tumor progression, but the …

Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer

H Araki, H Tazawa, N Kanaya, Y Kajiwara… - Molecular Therapy …, 2022 - cell.com
Immune checkpoint inhibitors, including anti-programmed cell death 1 (PD-1) antibody,
provide improved clinical outcome in certain cancers. However, pancreatic ductal …

High mobility group box 1: biological functions and relevance in oxidative stress related chronic diseases

S Taverna, A Tonacci, M Ferraro, G Cammarata… - Cells, 2022 - mdpi.com
In the early 1970s, a group of non-histone nuclear proteins with high electrophoretic mobility
was discovered and named high-mobility group (HMG) proteins. High-mobility group box 1 …

The receptor for Advanced Glycation endproducts (RAGE) and its ligands S100A8/A9 and high mobility Group Box protein 1 (HMGB1) are key regulators of myeloid …

S Ostrand-Rosenberg, T Huecksteadt, K Sanders - Cancers, 2023 - mdpi.com
Simple Summary Cancer immunotherapies using antibodies and genetically modified T
cells are effective in a subset of cancer patients. However, many cancer patients do not …

[HTML][HTML] HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases

X Zheng, J Lu, J Liu, L Zhou, Y He - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Cardiovascular disease (CVD) is the most fatal disease that causes sudden death, and
inflammation contributes substantially to its occurrence and progression. The prevalence of …